Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  AJP - Renal Physiology

• Publication date

  2012-08-01

• Fields of study

  Biology, Medicine, Environmental Science

• Identifiers
  DOI 10.1152/ajprenal.00111.2012PMID 22622461PMCID PMC3433869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Regulation of triglyceride metabolism by Angiopoietin-like proteins.

  2012cited by this paper
• Lipase maturation factor 1: a lipase chaperone involved in lipid metabolism.

  2012cited by this paper
• Uraemic sera stimulate lipolysis in human adipocytes: role of perilipin.

  2011cited by this paper
• Podocyte secreted Angiopoietin-like 4 mediates proteinuria in glucocorticoid sensitive nephrotic syndrome

  2010cited by this paper
• HDL metabolism and activity in chronic kidney disease

  2010cited by this paper
• Unexpected Expression Pattern for Glycosylphosphatidylinositol-anchored HDL-binding Protein 1 (GPIHBP1) in Mouse Tissues Revealed by Positron Emission Tomography Scanning*

  2010cited by this paper
• GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries.

  2010cited by this paper
• Adipose tissue as an endocrine organ.

  2010cited by this paper
• Nephrotoxicity from chemotherapeutic agents: clinical manifestations, pathobiology, and prevention/therapy.

  2010cited by this paper
• Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions.

  2010cited by this paper
• Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity.

  2009cited by this paper
• Lipoprotein lipase: from gene to obesity.

  2009cited by this paper
• Transgenic expression of proximal tubule peroxisome proliferator-activated receptor-alpha in mice confers protection during acute kidney injury.

  2009cited by this paper
• Cisplatin nephrotoxicity: mechanisms and renoprotective strategies.

  2008cited by this paper
• Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care

  2008cited by this paper
• Nutritional management in acute illness and acute kidney insufficiency.

  2007cited by this paper
• Biochemical mechanisms of cisplatin cytotoxicity.

  2007cited by this paper
• Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons.

  2007cited by this paper
• Long-term complications of platinum-based chemotherapy in testicular cancer survivors

  2007cited by this paper
• NF-kappaB is important for TNF-alpha-induced lipolysis in human adipocytes.

  2007cited by this paper
• Molecular mechanisms of resistance and toxicity associated with platinating agents.

  2007cited by this paper
• Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia

  2007cited by this paper
• Angiopoietin-like protein 4 converts lipoprotein lipase to inactive monomers and modulates lipase activity in adipose tissue

  2006cited by this paper
• Metabolomic study of cisplatin-induced nephrotoxicity.

  2006cited by this paper
• Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences.

  2006cited by this paper
• Lipotoxicity.

  2006cited by this paper
• APOA5 and triglyceride metabolism, lesson from human APOA5 deficiency.

  2006cited by this paper
• Genetics and regulation of angiopoietin-like proteins 3 and 4

  2006cited by this paper
• Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.

  2005cited by this paper
• Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.

  2005cited by this paper
• Insulin resistance in critically ill patients with acute renal failure.

  2005cited by this paper
• PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.

  2004cited by this paper
• Lipoprotein lipase in the kidney: activity varies widely among animal species.

  2004cited by this paper
• PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.

  2004cited by this paper
• Energy metabolism and cytotoxicity.

  2003cited by this paper
• Cisplatin nephrotoxicity.

  2003cited by this paper
• Lipotoxic diseases.

  2002cited by this paper
• Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP.

  2002cited by this paper
• Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure.

  2002cited by this paper
• TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.

  2002cited by this paper
• Lipoprotein lipase: structure, function, regulation, and role in disease

  2002cited by this paper
• Alterations of PPARα and its coactivator PGC-1 in cisplatin-induced acute renal failure

  2002cited by this paper
• TNF-α mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity

  2002cited by this paper
• Caloric and vitamin distribution by LpL 4. Synthesis and processing of lipases 5. Lipoproteins and regulation of the lipolysis reaction 6. Apolipoproteins 7. Non-enzymatic actions of lipoprotein lipase 8. Structure-function analysis of lipoprotein lipase 9.Genetic variation in lipoprotein lipase 10.

  2002cited by this paper
• Lipoprotein lipase: physiology, biochemistry, and molecular biology.

  2001cited by this paper
• Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ

  2001cited by this paper
• Adipose tissue as an endocrine organ.

  2000cited by this paper
• The Translational Regulation of Lipoprotein Lipase in Diabetic Rats Involves the 3′-Untranslated Region of the Lipoprotein Lipase mRNA*

  2000cited by this paper
• Characterization of the Fasting-induced Adipose Factor FIAF, a Novel Peroxisome Proliferator-activated Receptor Target Gene*

  2000cited by this paper
• Hyperlipidaemia in cisplatin-induced nephrotic rats

  1999cited by this paper
• Thiazolidinediones Inhibit Lipoprotein Lipase Activity in Adipocytes*

  1998cited by this paper
• Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure.

  1997cited by this paper
• Secondary hyperparathyroidism downregulates lipoprotein lipase expression in chronic renal failure.

  1997cited by this paper
• Down-regulation of tissue lipoprotein lipase expression in experimental chronic renal failure.

  1996cited by this paper
• Decreased clearance of low-density lipoprotein in patients with chronic renal failure.

  1994cited by this paper
• Regulation of the level of uncoupling protein in brown adipose tissue by insulin requires the mediation of the sympathetic nervous system

  1990cited by this paper
• Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.

  1989cited by this paper
• Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.

  1986cited by this paper
• Apolipoprotein C-II and lipoprotein lipase activity

  1982cited by this paper
• A stable, radioactive substrate emulsion for assay of lipoprotein lipase.

  1976cited by this paper

• Adipose Factor ANGPTL4: Its Role in Aging Mechanisms and Associated Diseases

  2025cites this paper
• The Effect of Low-Density Lipoprotein Receptor-Related Protein-1 on Acute Kidney Injury and Renal Tubular Epithelial Triglyceride Accumulation

  2025cites this paper
• Angiopoietin-Like Protein Family-Mediated Functions in Modulating Triglyceride Metabolism and Related Metabolic Diseases.

  2025cites this paper
• Angiopoietin-like protein 4 dysregulation in kidney diseases: a promising biomarker and therapeutic target

  2025cites this paper
• Renal lipid accumulation and aging linked to tubular cells injury via ANGPTL4.

  2024cites this paper
• The ANGPTL4-HIF-1α loop: a critical regulator of renal interstitial fibrosis

  2024cites this paper
• Hirsutidin Prevents Cisplatin-Evoked Renal Toxicity by Reducing Oxidative Stress/Inflammation and Restoring the Endogenous Enzymatic and Non-Enzymatic Level

  2023cites this paper
• Tripterygium glycosides improve abnormal lipid deposition in nephrotic syndrome rat models

  2023cites this paper
• The Roles of Fatty Acids and Apolipoproteins in the Kidneys

  2022cites this paper
• Blocking AMPK signalling to acetyl-CoA carboxylase increases cisplatin-induced acute kidney injury and suppresses the benefit of metformin.

  2022cites this paper
• Short‐term control of diet affects cisplatin‐induced acute kidney injury through modulation of mitochondrial dynamics and mitochondrial GSH

  2022influential citation
• ManNAc protects against podocyte pyroptosis via inhibiting mitochondrial damage and ROS/NLRP3 signaling pathway in diabetic kidney injury model.

  2022cites this paper
• Selective depletion of a CD64-expressing phagocyte subset mediates protection against toxic kidney injury and failure

  2021cites this paper
• Identification of Potential Gene and MicroRNA Biomarkers of Acute Kidney Injury

  2021influential citation
• Mechanism and reversal of drug-induced nephrotoxicity on a chip

  2021cites this paper
• Lipidomic approaches to dissect dysregulated lipid metabolism in kidney disease

  2021cites this paper
• Ameliorative Effects of the Aqueous Extract of Allium porrum (Wild Leek) against Cisplatin-Induced Nephrotoxicity in Rabbits

  2021cites this paper
• Triglyceride metabolism and angiopoietin-like proteins in lipoprotein lipase regulation.

  2020cites this paper
• Calcineurin inhibitors ameliorate PAN‐induced podocyte injury through the NFAT–Angptl4 pathway

  2020cites this paper
• Sirt3 modulates fatty acid oxidation and attenuates cisplatin‐induced AKI in mice

  2020cites this paper
• Alteration of Angiopoietin-Like Protein 4 Levels in Serum or Urine Correlate with Different Biochemical Markers in Hyperlipidemia-Related Proteinuria

  2020cites this paper
• PPAR α contributes to protection against metabolic and inflammatory derangements associated with acute kidney injury in experimental sepsis

  2019cites this paper
• Protective Effect of D-Methionine on Body Weight Loss, Anorexia, and Nephrotoxicity in Cisplatin-Induced Chronic Toxicity in Rats

  2018cites this paper
• Protective roles of fenofibrate against cisplatin‐induced ototoxicity by the rescue of peroxisomal and mitochondrial dysfunction

  2018cites this paper
• Exploring the impact of maternal obesity on offspring renal morphology and later life health

  2018cites this paper
• Metabolic characterization of directly reprogrammed renal tubular epithelial cells (iRECs)

  2018cites this paper
• Precision toxicology shows that troxerutin alleviates ochratoxin A–induced renal lipotoxicity

  2018cites this paper
• Physical exercise contributes to cisplatin‐induced nephrotoxicity protection with decreased CD4+ T cells activation

  2018cites this paper
• Pharmacological inhibition of NADPH oxidase protects against cisplatin induced nephrotoxicity in mice by two step mechanism.

  2015cites this paper
• Omega-3 Fatty Acids Protect Renal Functions by Increasing Docosahexaenoic Acid-Derived Metabolite Levels in SHR.Cg-Leprcp/NDmcr Rats, a Metabolic Syndrome Model

  2014cites this paper
• Altered renal lipid metabolism and renal lipid accumulation in human diabetic nephropathy

  2014cites this paper
• Relationship between apolipoprotein E gene polymorphism with triglyceride level in patients with renal diseases

  2013cites this paper